310 related articles for article (PubMed ID: 17143972)
21. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis.
Vallvé JC; Paredes S; Girona J; Uliaque K; Ribalta J; Hurt-Camejo E; Masana L
J Rheumatol; 2008 Sep; 35(9):1697-703. PubMed ID: 18634161
[TBL] [Abstract][Full Text] [Related]
23. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.
Shimane K; Kochi Y; Yamada R; Okada Y; Suzuki A; Miyatake A; Kubo M; Nakamura Y; Yamamoto K
Ann Rheum Dis; 2009 Mar; 68(3):377-83. PubMed ID: 18408250
[TBL] [Abstract][Full Text] [Related]
24. [Association between tumor necrosis factor alpha gene polymorphism and colorectal cancer].
Wu GY; Wang XM; Keese M; Hasenberg T; Sturm JW
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Nov; 11(6):569-71. PubMed ID: 19031138
[TBL] [Abstract][Full Text] [Related]
25. TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele.
Reich K; Hüffmeier U; König IR; Lascorz J; Lohmann J; Wendler J; Traupe H; Mössner R; Reis A; Burkhardt H
Arthritis Rheum; 2007 Jun; 56(6):2056-64. PubMed ID: 17530646
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women.
Padyukov L; Hytönen AM; Smolnikova M; Hahn-Zoric M; Nilsson N; Hanson LA; Tarkowski A; Klareskog L
J Rheumatol; 2004 Mar; 31(3):422-5. PubMed ID: 14994383
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
28. Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo.
Yazici AC; Erdal ME; Kaya TI; Ikizoglu G; Savasoglu K; Camdeviren H; Tursen U
Arch Dermatol Res; 2006 Jun; 298(1):46-9. PubMed ID: 16691430
[TBL] [Abstract][Full Text] [Related]
29. Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis.
Shih HH; Lin TM; Chuang JH; Eng HL; Juo SH; Huang FC; Chen CL; Chen HL
Pediatrics; 2005 Aug; 116(2):437-41. PubMed ID: 16061600
[TBL] [Abstract][Full Text] [Related]
30. Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis.
Cuchacovich M; Ferreira L; Aliste M; Soto L; Cuenca J; Cruzat A; Gatica H; Schiattino I; Pérez C; Aguirre A; Salazar-Onfray F; Aguillón JC
Scand J Rheumatol; 2004; 33(4):228-32. PubMed ID: 15370717
[TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma.
Liu CJ; Wong YK; Chang KW; Chang HC; Liu HF; Lee YJ
J Oral Pathol Med; 2005 Nov; 34(10):608-12. PubMed ID: 16202081
[TBL] [Abstract][Full Text] [Related]
32. [Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients].
Li Z; Li HQ; Yan Y; Liu Y; Hao W; Niu JQ; Yin JM; Li H
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2105-8. PubMed ID: 17988528
[TBL] [Abstract][Full Text] [Related]
33. Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population.
Zervou MI; Sidiropoulos P; Petraki E; Vazgiourakis V; Krasoudaki E; Raptopoulou A; Kritikos H; Choustoulaki E; Boumpas DT; Goulielmos GN
Hum Immunol; 2008 Sep; 69(9):567-71. PubMed ID: 18625278
[TBL] [Abstract][Full Text] [Related]
34. [Study on the association between gestational diabetes mellitus and tumor necrosis factor-alpha gene polymorphism].
Chang Y; Niu XM; Qi XM; Zhang HY; Li NJ; Luo Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):676-8. PubMed ID: 16277898
[TBL] [Abstract][Full Text] [Related]
35. Association between tumor necrosis factor-alpha gene promoter polymorphism at position -308 and acne in Turkish patients.
Baz K; Emin Erdal M; Yazici AC; Söylemez F; Güvenç U; Taşdelen B; Ikizoğlu G
Arch Dermatol Res; 2008 Aug; 300(7):371-6. PubMed ID: 18615253
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis.
Vargas-Alarcón G; Casasola-Vargas J; Rodríguez-Pérez JM; Huerta-Sil G; Pérez-Hernández N; Londoño J; Pacheco-Tena C; Cardiel MH; Granados J; Burgos-Vargas R
Hum Immunol; 2006 Oct; 67(10):826-32. PubMed ID: 17055360
[TBL] [Abstract][Full Text] [Related]
37. Association of tumor necrosis factor alpha and its receptor polymorphisms with rheumatoid arthritis in female patients.
Hussein YM; Mohamed RH; Pasha HF; El-Shahawy EE; Alzahrani SS
Cell Immunol; 2011; 271(1):192-6. PubMed ID: 21777909
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population.
Chang YH; Lee DS; Jo HS; Cho SI; Yoon HJ; Shin S; Yoon JH; Kim HY; Hong YJ; Hong SI; Cho HI
Cytokine; 2006 Oct; 36(1-2):45-50. PubMed ID: 17166738
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-18 gene (IL18) promoter polymorphisms in patients with rheumatoid arthritis.
Pawlik A; Kurzawski M; Drozdzik M; Dziedziejko V; Safranow K; Herczynska M
Scand J Rheumatol; 2009; 38(3):159-65. PubMed ID: 19229765
[TBL] [Abstract][Full Text] [Related]
40. Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor.
Marotte H; Arnaud B; Diasparra J; Zrioual S; Miossec P
Arthritis Rheum; 2008 May; 58(5):1258-63. PubMed ID: 18438841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
